← Back to Dashboard
AI-Driven Drug Design

Antibody

Origin Data Source OpenAlex
Analysis Computed Jul 3, 2026
AI Synthesis & Market Narrative
AI is enabling zero-shot design of drug-binding proteins with high accuracy, signaling a significant technical trend in de novo protein engineering for drug delivery and sequestration. Concurrently, new drugs are outperforming standard treatments for organ rejection, impacting transplant care.
Correlated Linguistic Patterns
["Zero-shot design of drug-binding proteins" "neural iterative selection-expansion" "drug delivery and sequestration" "drug to prevent organ rejection" "effective antibodies from chaos"]
Driving Media Context
Nature.com • Jul 1, 2026

A secreted endosymbiont protein essential for colonizing host cells

SyeA was present in the Buchnera ancestor, is secreted into the host cytoplasm, is homologous to secreted effectors of bacterial pathogens and is essential f...
Gizmodo.com • Jun 29, 2026

Man’s Suspected Brain Cancer Turns Out to Be Something Much Creepier

Multiple brain scans were required to find the true culprit behind the man's worsening headaches.
Yahoo Entertainment • Jun 24, 2026

Drug to prevent organ rejection after kidney transplant tops standard treatment in trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) June 24 (Reuters) - We also report o...
Nature.com • Jun 24, 2026

Zero-shot design of drug-binding proteins via neural iterative selection−expansion

 By pairing two neural networks in an iterative optimization algorithm, small-molecule binding proteins can be designed from scratch with high accuracy, affi...
Futurity: Research News • Jun 23, 2026

How the body makes effective antibodies from chaos

A new study in mice reveals how the immune system consistently produces highly effective antibodies.
Nature.com • Jun 21, 2026

Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months

Longitudinal antibody profiling in a Nicaraguan pediatric dengue cohort shows that cross-reactive IgG against the envelope protein rises, not wanes, over 18 ...
Themarginalian.org • Jun 21, 2026

Life Is a Story That Begins in the Middle: Bayo Akomolafe on the Rewilding Power of Obstacles

Whenever there is a will, there are two things: a way and an obstacle in the way — that place midway between desire and destination where one’s will collides...
Scientific American • Jun 16, 2026

Samagya Banskota

Using viruslike particles to deliver therapies safely and effectively
Refractor.io • Jun 12, 2026

Cause of inflammatory bowel disease discovered in traitorous antibody

The role of a traitorous antibody in triggering inflammatory bowel disease has been described in detail in a new study published this month in the New Englan...
Nature.com • Jun 9, 2026

Author Correction: A broadly protective antibody targeting gammaherpesvirus gB

Nature - Author Correction: A broadly protective antibody targeting gammaherpesvirus gB